Literature DB >> 30053081

Editorial: Novel Mechanism of Radioactive Iodine Refractivity in Thyroid Cancer.

Simona Paladino1, Rosa Marina Melillo1,2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 30053081     DOI： 10.1093/jnci/djx106

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN： 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  3 in total

Review 1.  Molecular mechanisms of radioactive iodine refractoriness in differentiated thyroid cancer: Impaired sodium iodide symporter (NIS) expression owing to altered signaling pathway activity and intracellular localization of NIS.

Authors:  Ji Min Oh; Byeong-Cheol Ahn
Journal:  Theranostics       Date:  2021-04-15       Impact factor: 11.556

Review 2.  Radioiodine-Refractory Thyroid Cancer: Molecular Basis of Redifferentiation Therapies, Management, and Novel Therapies.

Authors:  Mohamed Aashiq; Deborah A Silverman; Shorook Na'ara; Hideaki Takahashi; Moran Amit
Journal:  Cancers (Basel)       Date:  2019-09-17       Impact factor: 6.639

3.  The Association Between Radioiodine Refractory in Papillary Thyroid Carcinoma, Sodium/Iodide Symporter Expression, and BRAF V600E Mutation.

Authors:  Tauangtham Anekpuritanang; Maythad Uataya; Apichaya Claimon; Natthawadee Laokulrath; Warut Pongsapich; Paveena Pithuksurachai
Journal:  Onco Targets Ther       Date:  2021-06-29       Impact factor: 4.147
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.